ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Joint Structure"

  • Abstract Number: 1914 • ACR Convergence 2022

    Acoustic Classification of Early and Advanced Osteoarthritis of the Knee in Clinical Settings

    Dave Ewart1, Ashley Draisey2, Omer Inan3, Chris Nichols3 and Goktug Ozmen3, 1Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, 2Allina Health, Minneapolis, MN, 3Georgia Institute of Technology, Atlanta, GA

    Background/Purpose: Knee osteoarthritis (OA) is a prevalent and debilitating disease. Diagnosis of early knee OA is difficult and insensitive with current technologies. The human knee…
  • Abstract Number: 2205 • ACR Convergence 2022

    Non-Invasive in Vivo Metabolic Profiling of Inflammation in Joints and Entheses by Optoacoustic Imaging

    Koray Tascilar1, Filippo Fagni2, Arnd Kleyer1, Sara Bayat2, Robert Heidemann3, Florian Steiger3, Gerhard Kroenke1, Daniela Bohr4, Andreas Ramming1, Melek Yalcin Mutlu3, Ioanna Minopoulou3, Fabian Hartmann3, Daniel Klett5, Anna Federle5, Adrian Regensburger6, Alexandra L. Wagner6, Ferdinand Knieling6, Markus Neurath5, Georg Schett7, Maximilian Waldner5 and David Simon1, 1Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2University Hospital Erlangen; Department of Internal Medicine 3 - Rheumatology and Immunology, Erlangen, Germany, 3University Hospital Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology, Erlangen, Germany, 4Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and University Hospital Erlangen, Erlangen, Germany, 5University Hospital Erlangen; Department of Internal Medicine 1 - Gastroenterology, Pulmonology and Immunology, Erlangen, Germany, 6University Hospital Erlangen; Department of Pediatrics and Adolescent Medicine, Erlangen, Germany, 7Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: For individuals with inflammatory arthritis, a detailed metabolic characterization of joints and entheses at the tissue level can aid in early diagnosis and treatment…
  • Abstract Number: 2207 • ACR Convergence 2022

    Structural Ultrasound Features of Joints and Tendons of Healthy Children: Development of Normative Data

    Ruth Wittoek1, Céline Decock2, Nele Dewaele2, Lara Arnold3, Pieter baeyens4, Ignace Deschrijver4, Lisa Pardaens5, Ioannis Raftakis6, Thomas Renson7, Alexander D.J. Thooft8, Charline Rinkin9, Tine Vanhaverbeke5 and Caroline Verbist10, 1Dept. of Rheumatology, Ghent University Hospital, Ghent University, Gent, Belgium, 2Ghent University, Faculty of Medicine, Ghent, Belgium, 3Dept. Of Rheumatology, Maastricht UMC+, Maastricht, Netherlands, 4Dept. of Radiology, Clinique de Flandre, Coudekerque-Branche, France, 5Ghent University, Faculty of Internal Medicine and Pediatrics, Gent, Belgium, 6Dept. of Rheumatology, CHU-Brugmann Hospital Brussels, Brussels, Belgium, 7Ghent University Hospital, Ghent, Belgium, 8Ghent University, Faculty of Internal Medicine and Pediatrics, Ghent, Belgium, 9Dept. of Rheumatology, CHU Liège, Liège, Belgium, 10Dept. of Rheumatology, AZ Delta, Roeselare, Belgium, Roeselare, Belgium

    Background/Purpose: Ultrasound is a highly valuable imaging modality to study joints in patients with rheumatic diseases. In children, the applicability is hampered because of lack…
  • Abstract Number: 0267 • ACR Convergence 2022

    Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Malignancy: Results from the BIOBADASER Register

    Juan Molina1, Fernando Sanchez-Alonso2, Cristina Bohorquez3, Cesar Diaz-Torne4, Carolina Perez-Garcia5, Juan Maria Blanco-Madrigal6, Paloma Vela-Casampere7, José María Älvaro-Gracia1 and Isabel Castrejon8, 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain, 3University Hospital Príncipe de Asturias, Immune System Diseases-Rheumatology Service, Alcalá de Henares, Madrid, Spain, 4Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 5Department of Rheumatology, Hospital del Mar, Barcelona, Spain, 6Department of Rheumatology, Hospital de Basurto, Bilbao, Spain, 7Hospital General Universitario Alicante, Alicante, Spain, 8Hospital Universitario Gregorio Marañón, Madrid, Spain

    Background/Purpose: To investigate the occurrence and relative risk of incident malignancy in patients with rheumatic diseases and previous malignancy treated with biologic and targeted synthetic…
  • Abstract Number: 0404 • ACR Convergence 2022

    Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial

    Raphael Micheroli1, Tim Killeen2, Hyejin Jo3, Kenneth Kwok3, Bassel Elzorkany4, Caroline Ospelt5, Adrian Ciurea6 and Michael Nissen7, 1University Hospital Zurich, Department of Rheumatology, Zürich, Switzerland, 2Pfizer Ltd, Tadworth, Switzerland, 3Pfizer Inc, New York, NY, 4Department of Rheumatology, Cairo University, Cairo, Egypt, 5Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 6University Hospital Zurich, Zürich, Switzerland, 7Hopitaux Universitaires de Genève, Geneva, Switzerland

    Background/Purpose: Sites of peripheral joint and enthesitis involvement in AS vary. Tofacitinib is an oral Janus kinase inhibitor for the treatment of AS. Differential site-specific…
  • Abstract Number: 0504 • ACR Convergence 2022

    Three-dimensional Ground Reaction Force Symmetry Metrics Largely Fail to Explain Cartilage Worsening in the Contralateral Knee in Persons with Unilateral Knee Osteoarthritis: The Multicenter Osteoarthritis Study

    Patrick Corrigan1, Cara Lewis2, Kerry Costello2, Ali Guermazi2, Frank Roemer3, Deepak Kumar2, David Felson2, Kathryn Bacon2, Tuhina Neogi4, Michael LaValley5, Michael Nevitt6, Cora E. Lewis7, James Torner8 and Joshua Stefanik9, 1Saint Louis University, St. Louis, MO, 2Boston University, Boston, MA, 3Friedrich-Alexander University Erlangen Nürnberg, Erlangen, Germany, 4Boston University School of Medicine, Boston, MA, 5Boston University School of Public Health, Arlington, MA, 6University of California San Francisco, Orinda, CA, 7University of Alabama at Birmingham, Birmingham, AL, 8University of Iowa, Iowa City, IA, 9Northeastern University, Boston, MA

    Background/Purpose: Knee osteoarthritis (KOA) often starts as a unilateral disease and commonly progresses to bilateral KOA. There is a need to identify mechanisms that explain…
  • Abstract Number: 0610 • ACR Convergence 2022

    Patient-derived Organoids Reveal Transcriptional Regulation of Synovial Lining Fibroblast Differentiation

    Sonia Presti1, Gerald FM Watts1, Zhu Zhu1, Kartik Bhamidipati1, Junning Case1, Yuhong Li1, Teri Bowman1, Suppawat Kongthong1, ilya Korsunsky1, Michael Brenner2 and Kevin Wei3, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Synovial lining fibroblasts secrete factors into the joint cavity that promote joint lubrication1. In inflammatory arthritis, sublining fibroblasts undergo marked expansion while lining fibroblasts…
  • Abstract Number: 0803 • ACR Convergence 2022

    Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis

    Juan Carlos Cortés-Quiroz1, Javier Ena2, José Antonio Bernal3 and José Rosas4, 1Marina Baixa Hospital, Mutxamel, Spain, 2Department of Internal Medicine. Marina Baixa Hospital, Villajoyosa, Spain, 3Rheumatology Department. Marina Baixa Hospital, Alicante, Spain, 4Rheumatology Department, Hospital Marina Baixa, Villajoyosa, Spain

    Background/Purpose: Adenosine deaminase (ADA) activity has shown good performance in diagnosing pleural, peritoneal, and meningeal tuberculosis. This study aimed to evaluate the performance of measuring…
  • Abstract Number: 0972 • ACR Convergence 2022

    Automated Joint Space Width Measurement for Hand Osteoarthritis: A Deep Learning Approach

    Zhiheng Chang1, Juan Shan2, Yue Wang2, Xinyue Sun3, Jeffrey Driban4, Timothy McAlindon5, Jeffrey Duryea6, Lena Schaefer6, Charles Eaton7 and Ming Zhang8, 1Wentworth Institute of Technol, Boston, MA, 2Pace University, New York, NY, 3Shandong University, Qing Dao, Shandong, China, 4Tufts Medical Center, Westborough, MA, 5Tufts Medical Center, Arlington, MA, 6Brigham and Women's Hospital, Boston, MA, 7Brown University, Pawtucket, RI, 8Boston University, Westford, MA

    Background/Purpose: Hand osteoarthritis (OA) can be assessed visually through radiographs using Kellgren and Lawrence (KL) system. However, the KL grading system is not fully objective…
  • Abstract Number: 1511 • ACR Convergence 2022

    Is There a Correlation Between Skin and Musculoskeletal Activity in Psoriatic Arthritis

    Dafna Gladman1, Ghaydaa Aldabie2, Fangya Ma3, Mitchell Sutton4, Ker-Ai Lee3 and Richard Cook3, 1Toronto Western Hospital, Schroeder Arthritis Institute, Toronto, ON, Canada, 2Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 3University of Waterloo, Waterloo, ON, Canada, 4Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: The majority of patients with PsA present with skin manifestations first. Several studies have examined the relationship between activity/severity of skin and joint manifestations,…
  • Abstract Number: 0159 • ACR Convergence 2021

    Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?

    Xenofon Baraliakos1, Valeria Rios Rodriguez2, Murat Torgutalp2, Anil Dilbaryan2, Hildrun Haibel3, Maryna Verba4, Joachim Sieper3, Jürgen Braun1, Martin Rudwaleit5 and Denis Poddubnyy6, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Charité University Medicine Berlin, Berlin, Germany, 3Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 4Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Berlin, Germany, 5University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany, 6Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: The aim of this study is to investigate the performance of the modified Stokes Ankylosing Spondylitis Scoring System (mSASSS) in assessing spinal radiographic damage…
  • Abstract Number: 0737 • ACR Convergence 2021

    Enhanced Arthrocentesis of the Flexed Knee with Pneumatic Compression

    Sumir Brahmbhatt1, Ahsan Iqbal1, Fatemeh Farshami2, Maheswari Muruganandam3, Jaren Trost4, David Cisneros5, Adnan Kiani3, N. Suzanne Emil3, Sharon Nunez1, William Hayward6, Philip Band7 and Wilmer Sibbitt3, 1UNM, Albuquerque, NM, 2University of New Mexico, Albuquerque, MD, 3University of New Mexico, Albuquerque, NM, 4Optum, Albuquerque, NM, 5University of New Mexico School of Medicine, Albuquerque, NM, 6New Mexico Highlands University, Las Vegas, NM, 7NYU SOM, New York, NY

    Background/Purpose: To explore an alternative to standard extended knee arthrocentesis using pneumatic compression of the flexed knee.Methods: Using a paired sample design, 41 consecutive effusive…
  • Abstract Number: 0930 • ACR Convergence 2021

    Effect of Tofacitinib on Spinal Vertebral Body and Posterolateral Element Inflammation and Structural Lesions Using the Canada-Denmark MRI Scoring System in Patients with Ankylosing Spondylitis: Results from a Phase 2 Study

    Mikkel Ostergaard1, Joseph Wu2, Lara Fallon3, Sarah P Sherlock4, Cunshan Wang2, Dona L Fleishaker2, Keith S Kanik2 and Walter Maksymowych5, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, University of Copenhagen, Glostrup, Denmark, 2Pfizer Inc, Groton, CT, 3Pfizer Canada, Montréal, QC, Canada, 4Pfizer Inc, Cambridge, MA, 5Department of Medicine, University of Alberta, Alberta, Canada, Edmonton, AB, Canada

    Background/Purpose: The Canada-Denmark (CANDEN) MRI scoring system enables detailed anatomy-based evaluation of inflammatory and structural lesions in spinal vertebral bodies and posterior elements in patients…
  • Abstract Number: 1051 • ACR Convergence 2021

    Variance of Joint Space Width Across the Tibiofemoral Joint on Knee Radiographs: A Novel Measure of Structure and Progression

    Kent Kwoh1, Erin Ashbeck2, Edward Bedrick1, Xiaoxiao Sun1 and Jeffrey Duryea3, 1University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, Tucson, AZ, 3Brigham and Women's Hospital, Boston, MA

    Background/Purpose: The FDA accepts medial minimum joint space width (mJSW) in the tibiofemoral (TF) compartment as the standard for structural change in clinical trials of…
  • Abstract Number: 1349 • ACR Convergence 2021

    Joint-specific Responses to Tofacitinib and Adalimumab in Patients with Psoriatic Arthritis: Post Hoc Analysis of a Phase 3 Study

    Adrian Ciurea1, Tim Killeen2, Raphael Micheroli1, Norina N Gassman2, Hyejin Jo3, Kenneth Kwok4, Elizabeth Kudlacz4, Oliver Distler1, Caroline Ospelt5 and Mojca Frank-Bertoncelj1, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich/University of Zurich, Zurich, Switzerland, 2Pfizer AG, Zurich, Switzerland, 3Pfizer Inc, Groton, CT, 4Pfizer Inc, New York, NY, 5Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

    Background/Purpose: Peripheral joint involvement in PsA varies. In RA, varied joint involvement may reflect site-specific differences in stromal cell transcriptome, including Janus kinase-signal transducer and…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology